The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Mouse models of nonalcoholic steatohepatitis in preclinical drug development
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease in the Western world. NAFLD is a complex spectrum of liver diseases ranging from benign hepatic steatosis to its more aggressive necroinflammatory manifestation, nonalcoholic steatohepatitis (NASH). NASH pathogenesis is multifactorial and risk factors are almost identical to those of the metabolic syndrome. This has prompted substantial efforts to identify novel drug therapies for correcting underlying metabolic deficits, and to prevent or alleviate hepatic fibrosis in NASH. Available mouse models of NASH address different aspects of the disease, have varying clinical translatability, and, therefore, also show different utility in drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Armstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00803-x · Cited by 2,203
Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
The role of the gut microbiota in NAFLD
Leung, C., Rivera, L., Furness, J. B., & Angus, P. W. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.85 · Cited by 1,020
Targeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003
Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002
Bedossa, P., Poitou, C., Veyrie, N., Bouillot, J.-L., Basdevant, A., Paradis, V., Tordjman, J., & Clement, K. (2012) · Hepatology · doi:10.1002/hep.25889 · Cited by 903
White, D. L., Kanwal, F., & El–Serag, H. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.001 · Cited by 766
Csak, T., Ganz, M., Pespisa, J., Kodys, K., Dolganiuc, A., & Szabo, G. (2011) · Hepatology · doi:10.1002/hep.24341 · Cited by 645
The epidemiology of non‐alcoholic fatty liver disease
Bellentani, S. (2017) · Liver International · doi:10.1111/liv.13299 · Cited by 606
Inflammasome activation and function in liver disease
Szabo, G., & Petrasek, J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.94 · Cited by 597
Liang, W., Menke, A. L., Driessen, A., Koek, G. H., Lindeman, J. H., Stoop, R., Havekes, L. M., Kleemann, R., & van den Hoek, A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115922 · Cited by 577
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
Asgharpour, A., Cazanave, S. C., Pacana, T., Seneshaw, M., Vincent, R., Banini, B. A., Kumar, D. P., Daita, K., Min, H.-K., Mirshahi, F., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.005 · Cited by 538
An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis
Matsumoto, M., Hada, N., Sakamaki, Y., Uno, A., Shiga, T., Tanaka, C., Ito, T., Katsume, A., & Sudoh, M. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12008 · Cited by 523
The Effects of Cold and Lower Body Negative Pressure on Cardiovascular Homeostasis
Kean, D. J., Peacock, C. A., Sanders, G. J., McDaniel, J., Colvin, L. A. C., & Glickman, E. L. (2015) · BioMed Research International · doi:10.1155/2015/728145 · Cited by 492
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
Armstrong, M. J., Hull, D., Guo, K., Barton, D., Hazlehurst, J. M., Gathercole, L. L., Nasiri, M., Yu, J., Gough, S. C., Newsome, P. N., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.038 · Cited by 456
Staels, B., Rubenstrunk, A., Noel, B., Rigou, G., Delataille, P., Millatt, L. J., Baron, M., Lucas, A., Tailleux, A., Hum, D. W., et al. (2013) · Hepatology · doi:10.1002/hep.26461 · Cited by 414
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Musso, G., Cassader, M., & Gambino, R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.3 · Cited by 412
Leptin is essential for the hepatic fibrogenic response to chronic liver injury
Leclercq, I. A., Farrell, G. C., Schriemer, R., & Robertson, G. R. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00102-2 · Cited by 407
Genotoxicity of Streptozotocin
Bolzán, A. D., & Bianchi, M. S. (2002) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(02)00044-3 · Cited by 400
Ip, E., Farrell, G., Hall, P., Robertson, G., & Leclercq, I. (2004) · Hepatology · doi:10.1002/hep.20170 · Cited by 383
Molecular pathways in non-alcoholic fatty liver disease
Auguet, T., Berlanga, A., Guiu-Jurado, E., & Porras, J. A. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s62831 · Cited by 379
Tetri, L. H., Basaranoglu, M., Brunt, E. M., Yerian, L. M., & Neuschwander-Tetri, B. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90272.2008 · Cited by 378
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
Peverill, W., Powell, L., & Skoien, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058591 · Cited by 376
Fujii, M., Shibazaki, Y., Wakamatsu, K., Honda, Y., Kawauchi, Y., Suzuki, K., Arumugam, S., Watanabe, K., Ichida, T., Asakura, H., et al. (2013) · Medical Molecular Morphology · doi:10.1007/s00795-013-0016-1 · Cited by 355
Sanyal, A. J., Friedman, S. L., McCullough, A. J., & Dimick‐Santos, L. (2015) · Hepatology · doi:10.1002/hep.27678 · Cited by 354
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
Ferslew, B. C., Xie, G., Johnston, C. K., Su, M., Stewart, P. W., Jia, W., Brouwer, K. L. R., & Sidney Barritt, A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3776-8 · Cited by 335
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
Cui, J., Philo, L., Nguyen, P., Hofflich, H., Hernandez, C., Bettencourt, R., Richards, L., Salotti, J., Bhatt, A., Hooker, J., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.021 · Cited by 326
Lefebvre, E., Moyle, G., Reshef, R., Richman, L. P., Thompson, M., Hong, F., Chou, H.-L., Hashiguchi, T., Plato, C., Poulin, D., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158156 · Cited by 323
Pathology of non‐alcoholic fatty liver disease
Bedossa, P. (2017) · Liver International · doi:10.1111/liv.13301 · Cited by 322
Rau, M., Schilling, A.-K., Meertens, J., Hering, I., Weiss, J., Jurowich, C., Kudlich, T., Hermanns, H. M., Bantel, H., Beyersdorf, N., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501175 · Cited by 302
Clapper, J. R., Hendricks, M. D., Gu, G., Wittmer, C., Dolman, C. S., Herich, J., Athanacio, J., Villescaz, C., Ghosh, S. S., Heilig, J. S., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00079.2013 · Cited by 294
Marchesini, G., Petta, S., & Dalle Grave, R. (2016) · Hepatology · doi:10.1002/hep.28392 · Cited by 292
Zhang, S., Wang, J., Liu, Q., & Harnish, D. C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.025 · Cited by 290
Trevaskis, J. L., Griffin, P. S., Wittmer, C., Neuschwander-Tetri, B. A., Brunt, E. M., Dolman, C. S., Erickson, M. R., Napora, J., Parkes, D. G., & Roth, J. D. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00476.2011 · Cited by 277
Safadi, R., Konikoff, F. M., Mahamid, M., Zelber-Sagi, S., Halpern, M., Gilat, T., Oren, R., Safadi, R., Konikoff, F. M., Hershkovitz, A., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.038 · Cited by 274
Hepatic TLR4 signaling in obese NAFLD
Sharifnia, T., Antoun, J., Verriere, T. G. C., Suarez, G., Wattacheril, J., Wilson, K. T., Peek, R. M., Abumrad, N. N., & Flynn, C. R. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00304.2014 · Cited by 245
Specific Contribution of Methionine and Choline in Nutritional Nonalcoholic Steatohepatitis
Caballero, F., Fernández, A., Matías, N., Martínez, L., Fucho, R., Elena, M., Caballeria, J., Morales, A., Fernández-Checa, J. C., & García-Ruiz, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.099333 · Cited by 238
Teufel, A., Itzel, T., Erhart, W., Brosch, M., Wang, X. Y., Kim, Y. O., von Schönfels, W., Herrmann, A., Brückner, S., Stickel, F., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.05.051 · Cited by 229
Liver Transplantation for Nonalcoholic Steatohepatitis: The New Epidemic
Agopian, V. G., Kaldas, F. M., Hong, J. C., Whittaker, M., Holt, C., Rana, A., Zarrinpar, A., Petrowsky, H., Farmer, D., Yersiz, H., et al. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31826b4b7e · Cited by 228
Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition
Kluwe, J., Pradere, J., Gwak, G., Mencin, A., De Minicis, S., Österreicher, C. H., Colmenero, J., Bataller, R., & Schwabe, R. F. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.015 · Cited by 217
Friedman, S., Sanyal, A., Goodman, Z., Lefebvre, E., Gottwald, M., Fischer, L., & Ratziu, V. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.02.012 · Cited by 197
Immune and inflammatory pathways in NASH
Ganz, M., & Szabo, G. (2013) · Hepatology International · doi:10.1007/s12072-013-9468-6 · Cited by 184
Torres, D. M., Jones, F. J., Shaw, J. C., Williams, C. D., Ward, J. A., & Harrison, S. A. (2011) · Hepatology · doi:10.1002/hep.24558 · Cited by 183
Schierwagen, R., Maybüchen, L., Zimmer, S., Hittatiya, K., Bäck, C., Klein, S., Uschner, F. E., Reul, W., Boor, P., Nickenig, G., et al. (2015) · Scientific Reports · doi:10.1038/srep12931 · Cited by 179
Harrison, S. A., Marri, S. R., Chalasani, N., Kohli, R., Aronstein, W., Thompson, G. A., Irish, W., Miles, M. V., Xanthakos, S. A., Lawitz, E., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13816 · Cited by 176
Bieghs, V., Van Gorp, P. J., Wouters, K., Hendrikx, T., Gijbels, M. J., van Bilsen, M., Bakker, J., Binder, C. J., Lütjohann, D., Staels, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030668 · Cited by 175
Nonalcoholic steatohepatitis: a search for factual animal models
Sanches, S. C. L., Ramalho, L. N. Z., Augusto, M. J., da Silva, D. M., & Ramalho, F. S. (2015) · BioMed Research International · doi:10.1155/2015/574832 · Cited by 174
Patel, N. S., Doycheva, I., Peterson, M. R., Hooker, J., Kisselva, T., Schnabl, B., Seki, E., Sirlin, C. B., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.039 · Cited by 173
Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development
(2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2014.00035 · Cited by 171
Honda, Y., Imajo, K., Kato, T., Kessoku, T., Ogawa, Y., Tomeno, W., Kato, S., Mawatari, H., Fujita, K., Yoneda, M., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146337 · Cited by 170
Trak-Smayra, V. E., Paradis, V., Massart, J., Nasser, S. M., Jebara, V. A., & Fromenty, B. (2011) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2011.00793.x · Cited by 167
Arsov, T., Silva, D. G., O’Bryan, M. K., Sainsbury, A., Lee, N. J., Kennedy, C., Manji, S. S. M., Nelms, K., Liu, C., Vinuesa, C. G., et al. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0494 · Cited by 166
The liver diseases of lipodystrophy: The long-term effect of leptin treatment
Safar Zadeh, E., Lungu, A. O., Cochran, E. K., Brown, R. J., Ghany, M. G., Heller, T., Kleiner, D. E., & Gorden, P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.007 · Cited by 165
Ratziu, V., Sheikh, M. Y., Sanyal, A. J., Lim, J. K., Conjeevaram, H., Chalasani, N., Abdelmalek, M., Bakken, A., Renou, C., Palmer, M., et al. (2012) · Hepatology · doi:10.1002/hep.24747 · Cited by 164
The role of bile acids in metabolic regulation
Vítek, L., & Haluzík, M. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0469 · Cited by 164
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice
Zheng, S., Hoos, L., Cook, J., Tetzloff, G., Davis, H., van Heek, M., & Hwa, J. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.045 · Cited by 163
Harano, Y., Yasui, K., Toyama, T., Nakajima, T., Mitsuyoshi, H., Mimani, M., Hirasawa, T., Itoh, Y., & Okanoue, T. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01265.x · Cited by 161
Kargiotis, K., Athyros, V. G., Giouleme, O., Katsiki, N., Katsiki, E., Anagnostis, P. G., Boutari, C., Doumas, M., Karagiannis, A., & Mikhailidis, D. P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7860 · Cited by 147
Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease
Kostapanos, M. S., Κεή, Α., & Elisaf, M. S. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i9.470 · Cited by 147
Schwimmer, J. B., Lavine, J. E., Wilson, L., Neuschwander‐Tetri, B. A., Xanthakos, S. A., Kohli, R., Barlow, S. E., Vos, M. B., Karpen, S. J., Molleston, J. P., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.027 · Cited by 144
Carino, A., Cipriani, S., Marchianò, S., Biagioli, M., Santorelli, C., Donini, A., Zampella, A., Monti, M. C., & Fiorucci, S. (2017) · Scientific Reports · doi:10.1038/srep42801 · Cited by 137
Rooyen, D. M. V., Gan, L. T., Yeh, M. M., Haigh, W. G., Larter, C. Z., Ioannou, G. N., Teoh, N., & Farrell, G. C. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.024 · Cited by 132
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease
Bédossa, P., & Patel, K. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.008 · Cited by 132
Wang, Y., Parlevliet, E. T., Geerling, J. J., van der Tuin, S. J. L., Zhang, H., Bieghs, V, Jawad, A. H. M., Shiri‐Sverdlov, R., Bot, I., de Jager, S. C. A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12490 · Cited by 126
Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy
Kristiansen, M. N. B., Veidal, S. S., Rigbolt, K. T. G., Tølbøl, K. S., Roth, J. D., Jelsing, J., Vrang, N., & Feigh, M. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i16.673 · Cited by 126
Self-citationHonda, T., Ishigami, M., Luo, F., Lingyun, M., Ishizu, Y., Kuzuya, T., Hayashi, K., Nakano, I., Ishikawa, T., Feng, G., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2016.12.013 · Cited by 118
Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet
Koppe, S., Sahai, A., Malladi, P., Whitington, P. F., & Green, R. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.030 · Cited by 117
Stiede, K., Miao, W., Blanchette, H., Beysen, C., Harriman, G. C. B., Harwood, H. J., Kelley, H., Kapeller, R., Schmalbach, T., & Westlin, W. (2017) · Hepatology · doi:10.1002/hep.29246 · Cited by 117
Stefan, N., Ramsauer, M., Jordan, P., Nowotny, B., Kantartzis, K., Machann, J., Hwang, J., Nowotny, P., KAHL, S., Harreiter, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70170-0 · Cited by 115
Lee, J. H., Kang, Y. E., Chang, J. Y., Park, K. C., Kim, H.-W., Kim, J. T., Kim, H. J., Yi, H., Shong, M., Chung, H. K., et al. (2016) · PubMed · Cited by 114
IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression
Giles, D. A., Moreno‐Fernandez, M. E., & Divanovic, S. (2015) · Current Drug Targets · doi:10.2174/1389450116666150531153627 · Cited by 108
Valdecantos, M. P., Pardo, V., Ruiz, L., Castro‐Sánchez, L., Lanzón, B., Fernández‐Millán, E., García‐Monzón, C., Arroba, A. I., González‐Rodríguez, Á., Escrivá, F., et al. (2017) · Hepatology · doi:10.1002/hep.28962 · Cited by 100
Gupte, A. A., Liu, J. Z., Ren, Y., Minze, L. J., Wiles, J. R., Collins, A. R., Lyon, C. J., Praticò, D., Finegold, M. J., Wong, S. T. C., et al. (2010) · Hepatology · doi:10.1002/hep.23941 · Cited by 99
The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis
Griffett, K., Welch, R. D., Flaveny, C. A., Kolar, G. R., Neuschwander-Tetri, B. A., & Burris, T. P. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.01.009 · Cited by 95
Bile acid receptors and nonalcoholic fatty liver disease
Yuan, L., & Bambha, K. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i28.2811 · Cited by 89
Saito, K., Uebanso, T., Maekawa, K., Ishikawa, M., Taguchi, R., Nammo, T., Nishimaki‐Mogami, T., Udagawa, H., Fujii, M., Shibazaki, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep12466 · Cited by 86
Statins improve NASH via inhibition of RhoA and Ras
Schierwagen, R., Maybüchen, L., Hittatiya, K., Klein, S., Uschner, F. E., Braga, T. T., Franklin, B. S., Nickenig, G., Strassburg, C. P., Plat, J., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00063.2016 · Cited by 86
Farrell, G. C., Mridha, A. R., Yeh, M. M., Arsov, T., Van Rooyen, D. M., Brooling, J., Nguyen, T., Heydet, D., Delghingaro‐Augusto, V., Nolan, C. J., et al. (2014) · Liver International · doi:10.1111/liv.12335 · Cited by 85
Liu, W., Struik, D., Nies, V. J. M., Jurdzinski, A., Harkema, L., de Bruin, A., Verkade, H. J., Downes, M., Evans, R. M., van Zutphen, T., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525093113 · Cited by 84
Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation
Zhang, D.-G., Zhang, C., Wang, J., Wang, B.-W., Wang, H., Zhang, Z., Chen, Y., Lu, Y., Li, T., Wang, J., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.11.006 · Cited by 84
Optimized Mouse Models for Liver Fibrosis
Kim, Y. O., Popov, Y. V., & Schuppan, D. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6786-5_19 · Cited by 84
Mells, J. E., Fu, P. P., Kumar, P., Smith, T., Karpen, S. J., & Anania, F. A. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.11.002 · Cited by 83
Ezetimibe for the treatment of non‐alcoholic fatty liver disease: A meta‐analysis
Nakade, Y., Murotani, K., Inoue, T., Kobayashi, Y., Yamamoto, T., Ishii, N., Ohashi, T., Ito, K., Fukuzawa, Y., & Yoneda, M. (2017) · Hepatology Research · doi:10.1111/hepr.12887 · Cited by 83
Ohki, T., Isogawa, A., Toda, N., & Tagawa, K. (2016) · Clinical Drug Investigation · doi:10.1007/s40261-016-0383-1 · Cited by 82
Emerging therapeutic targets for the treatment of hepatic fibrosis
Fagone, P., Mangano, K., Pesce, A., Portale, T. R., Puleo, S., & Nicoletti, F. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.10.015 · Cited by 77
Tokushige, K., Hashimoto, E., Kodama, K., Tobari, M., Matsushita, N., Kogiso, T., Taniai, M., Torii, N., Shiratori, K., Nishizaki, Y., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0766-5 · Cited by 75
Kim, W. K., Kim, B. G., Lee, J. S., Lee, C. K., Yeon, J. E., Chang, M. S., Kim, J. H., Kim, H., Yi, S., Lee, J., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13981 · Cited by 75
Klein, T., Fujii, M., Sandel, J. P., Shibazaki, Y., Wakamatsu, K., Mark, M., & Yoneyama, H. (2013) · Medical Molecular Morphology · doi:10.1007/s00795-013-0053-9 · Cited by 71
Translational approaches: from fatty liver to non-alcoholic steatohepatitis.
Rosso, N., Chávez-Tapia, N. C., Tiribelli, C., & Bellentani, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i27.9038 · Cited by 65
Tang, W., Xu, Q., Hong, T., Tong, G., Feng, W., Shen, S., Bi, Y., & Zhu, D. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2713 · Cited by 63
Nakamura, I., Zakharia, K., Banini, B. A., Mikhail, D. S., Kim, T. H., Yang, J. D., Moser, C. D., Shaleh, H. M., Thornburgh, S. R., Walters, I. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092273 · Cited by 63
Chiba, T., Suzuki, S., Sato, Y., Itoh, T., & Umegaki, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164191 · Cited by 63
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis
McPherson, S., Wilkinson, N., TINIAKOS, D. G., Wilkinson, J. S., Burt, A. D., McColl, E., Stocken, D. D., Steen, N. D., Barnes, J. A., Goudie, N., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175717 · Cited by 60
Ratziu, V., Bédossa, P., Francque, S., Larrey, D. G., Aithal, G. P., Serfaty, L., Voiculescu, M., Preoțescu, L., Nevens, F., de Lédinghen, V., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.01.040 · Cited by 55
Zeng, T., Zhang, C., Zhao, X., & Xie, K.-Q. (2014) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000068 · Cited by 53
Interstrain differences in susceptibility to non‐alcoholic steatohepatitis
Yamazaki, Y., Kakizaki, S., Takizawa, D., Ichikawa, T., Sato, K., Takagi, H., & Mori, M. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05150.x · Cited by 49
Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice
Yamamoto, T. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i8.2512 · Cited by 47
Identification of novel targets for the diagnosis and treatment of liver fibrosis
Fagone, P., Mangano, K., Mammana, S., Pesce, A., PESCE, A., Caltabiano, R., Giorlandino, A., Portale, T. R., Cavalli, E., Lombardo, G. A. G., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2264 · Cited by 46
Haczeyni, F., Poekes, L., Wang, H., Mridha, A. R., Barn, V., Haigh, W. G., Ioannou, G. N., Yeh, M. M., Leclercq, I. A., Teoh, N., et al. (2016) · Obesity · doi:10.1002/oby.21701 · Cited by 46
The FLS mouse: a new inbred strain with spontaneous fatty liver.
Soga, M., Kishimoto, Y., kawaguchi, J., Nakai, Y., Kawamura, Y., Inagaki, S., Katoh, K., Oohara, T., Makino, S., & Oshima, I. (1999) · PubMed · Cited by 43
C/EBP homologous protein modulates liraglutide-mediated attenuation of non-alcoholic steatohepatitis
Rahman, K., Liu, Y., Kumar, P., Smith, T., Thorn, N. E., Farris, A. B., & Anania, F. A. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.61 · Cited by 39
How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?
Mann, J. P., Semple, R. K., & Armstrong, M. J. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00145 · Cited by 32
Liang, W., Verschuren, L., Mulder, P., van der Hoorn, J. W. A., Verheij, J., van Dam, A. D., Boon, M. R., Princen, H. M. G., Havekes, L. M., Kleemann, R., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13315 · Cited by 31
Shiffman, M. L., Freilich, B. L., Vuppalanchi, R., Watt, K. D. S., Burgess, G., Morris, M., Sheedy, B., & Schiff, E. R. (2015) · Journal of Hepatology · doi:10.1016/s0168-8278(15)30191-4 · Cited by 31
Bruckbauer, A., Banerjee, J., Fu, L., Li, F., Cao, Q., Cui, X., Wu, R., Shi, H., Xue, B., & Zemel, M. B. (2016) · International Journal of Hepatology · doi:10.1155/2016/9185987 · Cited by 28
Ohno, T., Shimizu, M., Shirakami, Y., Baba, A., Kochi, T., Kubota, M., Tsurumi, H., Tanaka, T., & Moriwaki, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124081 · Cited by 26
Onoyama, T., Koda, M., Okamoto, T., Kishina, M., Matono, T., Sugihara, T., & Murawaki, Y. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4329 · Cited by 24
F atty liver S hionogi‐ob/ob mouse: A new candidate for a non‐alcoholic steatohepatitis model
Sugihara, T., Koda, M., Kishina, M., Kato, J., Tokunaga, S., Matono, T., Ueki, M., & Murawaki, Y. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01101.x · Cited by 24
A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses
Wang, X., Ai, L., Xu, Q., Wu, C. W., Chen, Z., Su, D., Jiang, X., & Fan, Z. (2017) · Inflammation · doi:10.1007/s10753-017-0528-2 · Cited by 24
Wang, X., Sugimoto, K., Fujisawa, T., Shindo, N., Minato, S., Kamada, Y., Hamano, M., Ohishi, M., Ikegami, H., & Rakugi, H. (2013) · Hepatology Research · doi:10.1111/hepr.12092 · Cited by 23
Bahirat, U. A., Shenoy, R. R., Goel, R. N., & Nemmani, K. V. S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.043 · Cited by 23
Bell-Anderson, K. S., Aouad, L. J., Williams, H., Sanz, F. R., Phuyal, J. L., Larter, C. Z., Farrell, G. C., & Caterson, I. D. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.55 · Cited by 21
Orime, K., Shirakawa, J., Togashi, Y., Tajima, K., Inoue, H., Nagashima, Y., & Terauchi, Y. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.043 · Cited by 20
Sanyal, A. J., Tacke, F., Fischer, L., Vest, J., Ratziu, V., Seyedkazemi, S., Francque, S., Wiens, B. L., Aithal, G. P., Abdelmalek, M. F., et al. (2016) · RWTH Publications (RWTH Aachen) · Cited by 20
Okamoto, T., Koda, M., Miyoshi, K., Onoyama, T., Kishina, M., Matono, T., Sugihara, T., Hosho, K., Okano, J., Isomoto, H., et al. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i22.933 · Cited by 14
Liver Transplantation for Nonalcoholic Steatohepatitis
Asrani, S. K. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.11.014 · Cited by 9
Kim, J. H., Hong, H. N., Choi, H. H., et al. (2016) · Cited by 3
Cited by
Immune cell-mediated features of non-alcoholic steatohepatitis
Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573
Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
Van Herck, M., Vonghia, L., & Francque, S. (2017) · Nutrients · doi:10.3390/nu9101072 · Cited by 392
The ménage à trois of autophagy, lipid droplets and liver disease
Filali-Mouncef, Y., Hunter, C., Roccio, F., Zagkou, S., Dupont, N., Primard, C., Proikas-Cezanne, T., & Reggiori, F. (2022) · Autophagy · doi:10.1080/15548627.2021.1895658 · Cited by 361
Farrell, G., Schattenberg, J. M., Leclercq, I., Yeh, M. M., Goldin, R., Teoh, N., & Schuppan, D. (2019) · Hepatology · doi:10.1002/hep.30333 · Cited by 313
Boland, M. L., Laker, R. C., Mather, K., Nawrocki, A., Oldham, S., Boland, B. B., Lewis, H., Conway, J., Naylor, J., Guionaud, S., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0209-6 · Cited by 270
Self-citation
Metadata
- Authors
- Hansen, H. H., Feigh, M., Veidal, S. S., Rigbolt, K. T., Vrang, N., & Fosgerau, K.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 22
- Issue
- 11
- Pages
- 1707-1718
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2730267177
- Cited by
- 270
- References
- 126
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.